News

Athol Haas, Commercial Director at Fixed Phage

DATE: 27th October 2017
PUBLICATION: IntraFish



Athol Haas explains how Fixed Phage could hold the key to defeating EMS (and other aquaculture killers).

Related Articles

Pioneering UK biotechnology business, Fixed Phage, has secured additional investment to scale up its fight...
DATE: 15th March 2021

Pioneering UK biotechnology business, Fixed Phage, has secured additional investment to scale up its fight against new microbial threats that pose risks to human health and agricultural production. The company,...

Fixed Phage, (the “Company”) the UK biotechnology company developing and commercialising unique, anti-infective technologies based...
DATE: 26th May 2020

Fixed Phage, (the “Company”) the UK biotechnology company developing and commercialising unique, anti-infective technologies based on bacteriophage immobilisation and stabilisation, today announces the appointment of Dr Gordon Jamieson as Chief...

Carus Animal Health and British biotechnology company, Fixed Phage, have agreed a strategic collaboration in the...
DATE: 23rd March 2020

Carus Animal Health and British biotechnology company, Fixed Phage, have agreed a strategic collaboration in the companion animal field to identify, develop and commercialise stable and specific bacteriophages and their application...